We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy.
- Authors
Frechette, Kelsey M.; Lester, Scott C.; Taparra, Kekoa; Breen, William G.; Martenson, James A.; Hoppe, Bradford S.; Peterson, Jennifer L.; Rule, William G.; Stafford, Scott L.; Stish, Bradley J.; Habermann, Thomas M.; Young, Jason R.; Harmsen, William S.; Laack, Nadia N.
- Abstract
Outcomes of patients with stage I-II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy Combined modality therapy (CMT) consisting of chemotherapy followed by radiation therapy (RT) is an accepted standard of care for stage I-II Hodgkin lymphoma (HL). He played a key role in data acquisition, including review of all radiation therapy records to determine if patients were treated with involved field radiation therapy or involved site radiation therapy. INRT fields are appropriate with optimal pre-chemotherapy imaging [[5]], allowing fusion of a staging PET/CT scan to a post-chemotherapy RT planning CT scan.
- Subjects
HODGKIN'S disease; RADIOTHERAPY; TREATMENT effectiveness; SKIN cancer; RADIOTHERAPY treatment planning; COMBINED modality therapy
- Publication
Blood Cancer Journal, 2022, Vol 12, Issue 8, p1
- ISSN
2044-5385
- Publication type
Article
- DOI
10.1038/s41408-022-00711-8